Adverse events (assessed at any time during · adults having abdominal surgery
Epidural analgesia showed no clear difference in adverse events (assessed at any time during compared with intravenous patient‐controlled analgesia (low certainty).
1 finding from 1 review
Gastrointestinal adverse events · Women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
Metformin probably leads to higher adverse events (gastrointestinal) per woman compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Adverse events: paraesthesia ‐ not reported · patients undergoing lumbar punctures with traumatic needles (Quincke, Greene, Hingson Ferguson, Lutz, Brace, Rovenstine, Lemmon)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (proportion) (4 to 6 months) · people with acute HBV infection
Interferon may leads to higher adverse events (proportion) (4 to 6 months) compared with no intervention (low certainty).
1 finding from 1 review
Adverse events: arteriovenous complications · anaemia in predialysis patients
Epoetin alfa every four weeks showed no clear difference in adverse events: arteriovenous complications compared with with every two weeks (low certainty).
1 finding from 1 review
Intervention not reported
Severe adverse events: raised transaminases · antiretroviral‐naïve individuals
The intervention leads to lower severe adverse events: raised transaminases (high certainty).
1 finding from 1 review
Intervention not reported
Severe adverse events: raised triglycerides · antiretroviral‐naïve individuals
The intervention showed no clear difference in severe adverse events: raised triglycerides (low certainty).
1 finding from 1 review
Intervention not reported
Topical ketoprofen gel Local adverse events · adults with chronic musculoskeletal pain (osteoarthritis)
1 finding from 1 review
Shivering · patients with rapid emergence from anaesthesia after undergoing brain tumour surgery
Propofol showed no clear difference in adverse event ‐ shivering, number of events compared with sevoflurane (low certainty).
1 finding from 1 review
Major adverse events · patients with muscle cramps
1 finding from 1 review
Minor adverse events · patients with muscle cramps
1 finding from 1 review
Major adverse events · patients with muscle cramps
1 finding from 1 review
Minor adverse events · patients with muscle cramps
1 finding from 1 review
Major adverse events · patients with muscle cramps
1 finding from 1 review
Minor adverse events · patients with muscle cramps
1 finding from 1 review
Withdrawals due to adverse events · children and young people with JIA
Oral methotrexate plus intra‐articular glucocorticoid showed no clear difference in withdrawals due to adverse events(12 months) compared with intra‐articular glucocorticoid alone (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · active EoE pediatric patients
It is very uncertain whether mepolizumab 10 mg/kg changes withdrawals due to adverse events at 8 weeks compared with mepolizumab 0.55 mg/kg (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · active EoE pediatric patients
It is very uncertain whether mepolizumab 2.5 mg/kg changes withdrawals due to adverse events at 8 weeks compared with mepolizumab 0.55 mg/kg (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · active EoE pediatric patients
It is very uncertain whether mepolizumab 10 mg/kg changes withdrawals due to adverse events at 8 weeks compared with mepolizumab 2.5 mg/kg (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · active EoE pediatric patients
Cromolyn sodium showed no clear difference in withdrawals due to adverse events at 8 weeks compared with placebo (low certainty).
1 finding from 1 review